PISCATAWAY, N.J. — The U.S. subsidiary of India-based generic drug maker Hetero Drugs has appointed Konstantin Ostaficiuk as its president, Camber said.
Ostaficiuk, who often goes by the nickname of Kon, succeeds Briggs Arrington, who has gone on to work for Hetero’s senior management team to find new opportunities for the company’s U.S. manufacturing operations. Ostaficiuk has worked in the generic drug industry for 25 years, having joined Camber in 2009 as VP sales and marketing.
“Camber and Hetero have a very robust pipeline and will continue to introduce and launch significant new products to our current portfolio in the remainder of 2011, 2012 and on into the future,” Ostaficiuk said. “We are committed to providing the highest level of quality and service available as we grow our business and our product line.”